奥翔药业 (603229.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(奥翔药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 300,914,417.10816,765,083.27671,662,047.60468,715,612.42262,549,690.48764,547,389.04577,913,726.42381,360,543.87205,113,465.95
 营业利润(元) 130,357,297.50290,823,300.94255,859,503.40183,655,642.61109,002,232.05257,714,652.65203,346,280.06141,397,655.8481,118,636.93
 利润总额(元) 130,010,300.64290,762,311.74256,285,022.70183,654,384.18109,002,213.07255,859,016.61202,971,429.35141,202,568.1981,050,386.93
 净利润(元) 112,480,834.45253,901,967.43225,337,632.82160,196,748.3393,672,808.45235,375,827.46177,077,646.30123,023,476.5470,722,644.75
 归属于母公司股东的净利润(元) 112,480,834.45253,901,967.43225,337,632.82160,196,748.3393,672,808.45235,375,827.46177,077,646.30123,023,476.5470,722,644.75
盈利能力:
 销售毛利率(%) 58.2955.0557.6758.0058.8951.5050.6551.1155.64
 销售净利率(%) 37.3831.0933.5534.1835.6830.7930.6432.2634.48
 净资产收益率(%) 5.2414.1012.829.305.59----
 总资产报酬率ROA(%) 4.189.768.615.974.47----
 投入资本回报率ROIC(%) 4.2911.5310.167.154.2913.7610.267.294.37
营运能力:
 存货周转率(次) 0.391.070.890.630.37----
 应收账款周转率(次) 1.306.113.032.371.42----
 总资产周转率(次) 0.100.310.260.180.11----
偿债能力:
 资产负债率(%) 25.6627.4428.9330.4730.1036.8937.3336.5931.72
 股东权益比率(%) 74.3472.5671.0769.5369.9063.1162.6763.4168.28
 已获利息倍数(倍) -21.21-7.64-7.05-5.09-172.63-5.06-3.65-5.4243.21
 流动比率 2.382.172.242.142.191.521.601.682.00
 速动比率 1.951.691.781.741.751.091.181.241.54
发展能力:
 营业收入增长率(%) 14.616.8316.2222.9128.0034.2034.5033.5142.45
 营业利润增长率(%) 19.5912.8525.8229.8934.3760.9266.1453.0165.49
 税后利润增长率(%) 20.087.8727.2530.2232.4561.2960.5248.7861.18
 净资产增长率(%) 11.5946.5750.6255.3553.0416.4415.0711.5213.21
 总资产增长率(%) 4.9227.4832.8241.6649.5125.8733.7936.6340.44

前瞻产业研究院